{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:03:33Z","timestamp":1792069413506,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ebiom.2024.105132","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:21:47Z","timestamp":1714116107000},"page":"105132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2 -infected mice and reduces endotheliopathy"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1846-0606","authenticated-orcid":false,"given":"Mar\u00eda \u00c1ngeles","family":"Rodr\u00edguez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Baena-Bustos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Zurita-Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mu\u00f1oz-Pinillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Padillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Smerdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayetano","family":"von Kobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rose-John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Bustos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib1","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1038\/s41467-023-41109-9","article-title":"Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection","volume":"14","author":"Mongin","year":"2023","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105132_bib2","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ebiom.2024.105132_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: a review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin Immunol"},{"issue":"620","key":"10.1016\/j.ebiom.2024.105132_bib4","article-title":"Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19","volume":"13","author":"D'Agnillo","year":"2021","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105132_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41401-022-00998-0","article-title":"Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies","volume":"44","author":"Xu","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105132_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.ebiom.2024.105132_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108448","article-title":"COVID-19: immunology and treatment options","volume":"215","author":"Felsenstein","year":"2020","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105132_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41575-021-00473-x","article-title":"New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology","volume":"18","author":"Giraldez","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105132_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J\u00a0Exp Med"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105132_bib10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2024.105132_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.891456","article-title":"Identification of IL-6 signalling components as predictors of severity and outcome in COVID-19","volume":"13","author":"Rodr\u00edguez-Hern\u00e1ndez","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105132_bib12","article-title":"Interleukin-6 blocking agents for treating COVID-19: a living systematic review","volume":"3","author":"Ghosn","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib13","first-page":"24","article-title":"Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review)","volume":"21","author":"Chen","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ebiom.2024.105132_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.825749","article-title":"Tocilizumab and COVID-19: timing of administration and efficacy","volume":"13","author":"Abidi","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmi.2022.07.008","article-title":"Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis","volume":"29","author":"Albuquerque","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105132_bib16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/rheumatology\/ker223","article-title":"Risk of infections in rheumatoid arthritis patients treated with tocilizumab","volume":"51","author":"Lang","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105132_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2295","article-title":"Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: a systematic review and meta-analysis","volume":"32","author":"Peng","year":"2022","journal-title":"Rev Med Virol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105132_bib18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41577-023-00856-y","article-title":"Targeting IL-6 trans-signalling: past, present and future prospects","volume":"23","author":"Rose-John","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105132_bib19","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1053\/j.gastro.2021.02.062","article-title":"Therapeutic interleukin-6 trans-signaling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease","volume":"160","author":"Schreiber","year":"2021","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105132_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.2023.1084","article-title":"Effect of induction therapy with olamkicept vs placebo on clinical response in patients with active ulcerative colitis: a randomized clinical trial","volume":"329","author":"Zhang","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105132_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01622-21","article-title":"A\u00a0hybrid soluble gp130\/spike-nanobody fusion protein simultaneously blocks interleukin-6 trans-signaling and cellular infection with SARS-CoV-2","volume":"96","author":"Ettich","year":"2022","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2024.105132_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103291","article-title":"Bridging animal and clinical research during SARS-CoV-2 pandemic: a new-old challenge","volume":"66","author":"Winkler","year":"2021","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00964-21","article-title":"The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus","volume":"96","author":"Dong","year":"2022","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib24","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41467-020-19891-7","article-title":"Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice","volume":"11","author":"Oladunni","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib25","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1038\/s41467-021-26803-w","article-title":"SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains","volume":"12","author":"Radvak","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105132_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110387","article-title":"SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models","volume":"38","author":"Stolp","year":"2022","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105132_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13771","article-title":"Treatment with the senolytics dasatinib\/quercetin reduces SARS-CoV-2-related mortality in mice","volume":"22","author":"Pastor-Fernandez","year":"2023","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cell.2020.05.027","article-title":"Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2","volume":"182","author":"Jiang","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib29","first-page":"41","article-title":"Examining male predominance of severe COVID-19 outcomes: a systematic review","volume":"3","author":"Twitchell","year":"2022","journal-title":"Androg Clin Res Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105132_bib30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/CCM.0b013e318211ff56","article-title":"Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model","volume":"39","author":"Barkhausen","year":"2011","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib31","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1080\/22221751.2021.1978823","article-title":"Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses","volume":"10","author":"Aparicio","year":"2021","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105132_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","article-title":"Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses","volume":"268","author":"Jostock","year":"2001","journal-title":"Eur J Biochem"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105132_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100179","article-title":"Impact of P-selectin-PSGL-1 Axis on platelet-endothelium-leukocyte interactions in fatal COVID-19","volume":"103","author":"Granai","year":"2023","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105132_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2021.04.050","article-title":"Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy","volume":"75","author":"McConnell","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105132_bib35","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/ATVBAHA.123.319695","article-title":"Simultaneous targeting of IL-1-signaling and IL-6-trans-signaling preserves human pulmonary endothelial barrier function during a cytokine storm-brief report","volume":"43","author":"Colas-Algora","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7860","key":"10.1016\/j.ebiom.2024.105132_bib36","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41586-021-03475-6","article-title":"The spatial landscape of lung pathology during COVID-19 progression","volume":"593","author":"Rendeiro","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105132_bib37","article-title":"Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome","volume":"2","author":"Chen","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2024.105132_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.650331","article-title":"Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-siglec-8 antibody","volume":"12","author":"Gebremeskel","year":"2021","journal-title":"Front Immunol"},{"issue":"7362","key":"10.1016\/j.ebiom.2024.105132_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature10357","article-title":"The ageing systemic milieu negatively regulates neurogenesis and cognitive function","volume":"477","author":"Villeda","year":"2011","journal-title":"Nature"},{"issue":"6508","key":"10.1016\/j.ebiom.2024.105132_bib40","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105132_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/toxins14100673","article-title":"Cytokine and chemokine retention profile in COVID-19 patients with chronic kidney disease","volume":"14","author":"Ciceri","year":"2022","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105132_bib42","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/v13040639","article-title":"Vascular inflammation is associated with loss of aquaporin 1 expression on endothelial cells and increased fluid leakage in SARS-CoV-2 infected golden Syrian hamsters","volume":"13","author":"Allnoch","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105132_bib43","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/imm.13603","article-title":"Dysfunctional phenotype of systemic and pulmonary regulatory T cells associate with lethal COVID-19 cases","volume":"168","author":"Goncalves-Pereira","year":"2023","journal-title":"Immunology"},{"issue":"7843","key":"10.1016\/j.ebiom.2024.105132_bib44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-020-2943-z","article-title":"COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice","volume":"589","author":"Zheng","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105132_bib45","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105132_bib46","first-page":"159","article-title":"Activation and injury of endothelial cells by cytokines","volume":"46","author":"Pober","year":"1998","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ebiom.2024.105132_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106829","article-title":"Endothelial cells and SARS-CoV-2: an intimate relationship","volume":"137","author":"Barbosa","year":"2021","journal-title":"Vascul Pharmacol"},{"issue":"20","key":"10.1016\/j.ebiom.2024.105132_bib48","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/CIRCULATIONAHA.122.059231","article-title":"A\u00a0role for the vascular endothelium in post-acute COVID-19?","volume":"145","author":"de Rooij","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105132_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/v14020211","article-title":"The role of von Willebrand factor in the pathogenesis of pulmonary vascular thrombosis in COVID-19","volume":"14","author":"Babkina","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2024.105132_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103812","article-title":"Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs","volume":"75","author":"Won","year":"2022","journal-title":"eBioMedicine"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105132_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2022.2090792","article-title":"Roles of the ACE\/Ang II\/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis","volume":"11","author":"Ashour","year":"2023","journal-title":"Tissue Barriers"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105132_bib52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","article-title":"Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment","volume":"6","author":"Romano","year":"1997","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105132_bib53","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.4049\/jimmunol.163.8.4583","article-title":"Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor","volume":"163","author":"Klouche","year":"1999","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105132_bib54","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.immuni.2023.03.021","article-title":"The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation","volume":"56","author":"Gatsiou","year":"2023","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105132_bib55","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105132_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009128","article-title":"SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells","volume":"16","author":"Patra","year":"2020","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105132_bib57","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaci.2018.05.026","article-title":"Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation","volume":"143","author":"Jevnikar","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2024.105132_bib58","first-page":"S11","article-title":"Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis","volume":"65","author":"Cronstein","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105132_bib59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000341698","article-title":"Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease","volume":"30","author":"Chalaris","year":"2012","journal-title":"Dig Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105132_bib60","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1523\/JNEUROSCI.2830-13.2014","article-title":"Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain","volume":"34","author":"Campbell","year":"2014","journal-title":"J\u00a0Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105132_bib61","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting interleukin-6 signaling in clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"issue":"6469","key":"10.1016\/j.ebiom.2024.105132_bib62","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","article-title":"Impaired immune and acute-phase responses in interleukin-6-deficient mice","volume":"368","author":"Kopf","year":"1994","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105132_bib63","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/annrheumdis-2018-214367","article-title":"Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study","volume":"78","author":"Pawar","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105132_bib64","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S2213-2600(21)00358-1","article-title":"Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial","volume":"9","author":"Kalil","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105132_bib65","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105132_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105967","article-title":"Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19","volume":"55","author":"Praveen","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ebiom.2024.105132_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1220306","article-title":"SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling","volume":"14","author":"Lopez-Ayllon","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105132_bib68","article-title":"Integrated immune dynamics define correlates of COVID-19 severity and antibody responses","volume":"2","author":"Koutsakos","year":"2021","journal-title":"Cell Rep Med"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105132_bib69","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.4049\/jimmunol.180.11.7102","article-title":"Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells","volume":"180","author":"Briso","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105132_bib70","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41587-021-01155-4","article-title":"A\u00a0humanized mouse model of chronic COVID-19","volume":"40","author":"Sefik","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105132_bib71","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2024.105132_bib72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ebiom.2019.07.058","article-title":"Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling","volume":"46","author":"Wang","year":"2019","journal-title":"eBioMedicine"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105132_bib73","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","article-title":"Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms","volume":"53","author":"Kang","year":"2021","journal-title":"Exp Mol Med"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T02:44:55Z","timestamp":1738464295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424001671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":73,"alternative-id":["S2352396424001671"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105132","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2 -infected mice and reduces endotheliopathy","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105132"}}